Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Is Any Additional Information Gained Regarding Margins Using 3D Tomosynthesis Vs 2D Conventional Digital Imaging When Imaging Operative Breast Specimens?

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
Jennifer Waldron, Sandwell & West Birmingham Hospitals NHS Trust
ClinicalTrials.gov Identifier:
NCT02096185
First received: March 21, 2014
Last updated: October 19, 2016
Last verified: November 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is enrolling participants by invitation only.
  Estimated Study Completion Date: May 2017
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)